MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202617062074 A) filed by Biontech Zhuhai Pharmaceuticals R&d Co. , Ltd on May 15, 2026, for Bispecific Antibody Against Ccr8 And Ctla4.
Inventors include Chen, Liandi; Luo, Yi; Miao, Xiaoniu; Zhai, Tianhang; Huang, Weifeng; and Tsun, Andy.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: An antibody or an antigen-binding fragment thereof and a single-domain antibody or an antigen-binding fragment thereof that can specifically bind to CTLA4, and an immunoconjugate, a pharmaceutical composition and a multispecific molecule comprising the antibody or the antigen-binding fragment thereof. Furthermore, the present invention also relates to a multispecific molecule that can specifically bind to CCR8 and CTLA4 and the use thereof.
Disclaimer: Curated by HT Syndication.
